February 03, 2021
2 min watch
Save
VIDEO: Rajpal discusses Tecnis Eyhance FDA approvals
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video exclusive, Rajesh K. Rajpal, MD, chief medical officer and global head of clinical and medical affairs at Johnson & Johnson Vision, discusses the recent FDA approvals of the Tecnis Eyhance and Eyhance toric II IOLs.